Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Humans is Diminished by Priming with a Yellow Fever or Japanese Encephalitis Virus Vaccine: Elucidating Immunologic Interference between Flavivirus Vaccines
Kayvon Modjarrad(Walter Reed Army Institute of Research), Nelson L. Michael(Walter Reed Army Institute of Research), Mihret F. Amare(Henry M. Jackson Foundation), Michael A. Eller(Henry M. Jackson Foundation), Gordon Joyce(Walter Reed Army Institute of Research), Margaret C. Costanzo(Henry M. Jackson Foundation), Vincent Dussupt(Henry M. Jackson Foundation), Gregory D. Gromowski(Walter Reed Army Institute of Research), Stephen J. Thomas(Walter Reed Army Institute of Research), Shelly J. Krebs(Henry M. Jackson Foundation), Kenneth H. Eckels(Walter Reed Army Institute of Research), Richard G. Jarman(Walter Reed Army Institute of Research), Erica L Sondergaard(Walter Reed Army Institute of Research), Michael Koren(Jacksonville University), Casey K. Storme(Walter Reed Army Institute of Research), Leyi Lin(Walter Reed Army Institute of Research), Rafael De La Barrera(Walter Reed Army Institute of Research)
Cited by 1
Related Papers
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
|Nature|2012|466
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
|New England Journal of Medicine|2015|390
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
|The Lancet|2018|342
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
|Vaccine|2011|307
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
|Nature Medicine|2011|227